Skip to main content
OpenTrials

Clinical trial condition

Bronchial Diseases

Explore clinical trials studying Bronchial Diseases. Study availability and eligibility vary by location and protocol.

4,805 public trials 452 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Diseases trial results

Completed

Effect of BIBW 2948 BS in COPD

NCT00423137

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +10 more
Locations
  • 1219.5.03 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1219.5.01 Boehringer Ingelheim Investigational Site San Francisco, California, United States
  • 1219.5.02 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
  • 1219.5.04 Boehringer Ingelheim Investigational Site Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Albuterol HFA MDI in Pediatric Participants With Asthma

NCT00577655

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Pediatric Care Medical Group, Inc. Huntington Beach, California, United States
  • California Allergy & Asthma Medical Group Palmdale, California, United States
  • Center for Clinical Trials, LLC Paramount, California, United States
  • Integrated Research Group, Inc Riverside, California, United States
View all 13 locations
View Trial Details
Completed

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

NCT02139644

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12397 Birmingham, Alabama, United States
  • Teva Investigational Site 12375 Glendale, Arizona, United States
  • Teva Investigational Site 12395 Cypress, California, United States
  • Teva Investigational Site 12476 Encinitas, California, United States
View all 140 locations
View Trial Details
Completed

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

NCT02452190

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 13212 Birmingham, Alabama, United States
  • Teva Investigational Site 13241 Flagstaff, Arizona, United States
  • Teva Investigational Site 13194 Glendale, Arkansas, United States
  • Teva Investigational Site 13215 Bakersfield, California, United States
View all 226 locations
View Trial Details
Completed

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

NCT02040779

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Teva Investigational Site 12813 Huntington Beach, California, United States
  • Teva Investigational Site 10944 Mission Viejo, California, United States
  • Teva Investigational Site 10946 Orange, California, United States
  • Teva Investigational Site 10963 Rolling Hills Estates, California, United States
View all 47 locations
View Trial Details
Completed

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

NCT02031640

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 10851 Costa Mesa, California, United States
  • Teva Investigational Site 10849 Huntington Beach, California, United States
  • Teva Investigational Site 10872 Huntington Beach, California, United States
  • Teva Investigational Site 10833 Long Beach, California, United States
View all 131 locations
View Trial Details

Related conditions